Patient Guide: DEVOTE: Phase 2/3 study evaluating high-dose nusinersen (50 mg loading, 28 mg maintenance) vs 12 mg regimen in spinal muscular atrophy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTDEVOTE
Status: COMPLETED
Condition: Spinal Muscular Atrophy
Phase: PHASE2, PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily